• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Immunol . A patient-centric modeling framework captures recovery from SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Nat Immunol


. 2023 Jan 30.
doi: 10.1038/s41590-022-01380-2. Online ahead of print.
A patient-centric modeling framework captures recovery from SARS-CoV-2 infection




Hélène Ruffieux[SUP] 1 [/SUP], Aimee L Hanson[SUP] 2 3 [/SUP], Samantha Lodge[SUP] 4 5 [/SUP], Nathan G Lawler[SUP] 4 5 [/SUP], Luke Whiley[SUP] 4 5 6 [/SUP], Nicola Gray[SUP] 4 5 [/SUP], Tui H Nolan[SUP] 7 [/SUP], Laura Bergamaschi[SUP] 2 3 [/SUP], Federica Mescia[SUP] 2 3 [/SUP], Lorinda Turner[SUP] 2 3 [/SUP], Aloka de Sa[SUP] 2 3 [/SUP], Victoria S Pelly[SUP] 2 3 [/SUP]; Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) BioResource COVID-19 Collaboration; Prasanti Kotagiri[SUP] 2 3 [/SUP], Nathalie Kingston[SUP] 8 9 [/SUP], John R Bradley[SUP] 3 9 [/SUP], Elaine Holmes[SUP] 4 5 10 [/SUP], Julien Wist[SUP] 4 5 11 [/SUP], Jeremy K Nicholson[SUP] 4 5 12 [/SUP], Paul A Lyons[SUP] 2 3 [/SUP], Kenneth G C Smith[SUP] 2 3 [/SUP], Sylvia Richardson[SUP] 7 [/SUP], Glenn R Bantug[SUP] 13 14 [/SUP], Christoph Hess[SUP] 15 16 17 18 [/SUP]



Affiliations

Abstract

The biology driving individual patient responses to severe acute respiratory syndrome coronavirus 2 infection remains ill understood. Here, we developed a patient-centric framework leveraging detailed longitudinal phenotyping data and covering a year after disease onset, from 215 infected individuals with differing disease severities. Our analyses revealed distinct 'systemic recovery' profiles, with specific progression and resolution of the inflammatory, immune cell, metabolic and clinical responses. In particular, we found a strong inter-patient and intra-patient temporal covariation of innate immune cell numbers, kynurenine metabolites and lipid metabolites, which highlighted candidate immunologic and metabolic pathways influencing the restoration of homeostasis, the risk of death and that of long COVID. Based on these data, we identified a composite signature predictive of systemic recovery, using a joint model on cellular and molecular parameters measured soon after disease onset. New predictions can be generated using the online tool http://shiny.mrc-bsu.cam.ac.uk/apps/covid-19-systemic-recovery-prediction-app , designed to test our findings prospectively.
 
Back
Top Bottom